Attention AACR Annual Meeting 2017 Registrants – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

Clinical Trial Paradigms in the Era of Novel Therapies

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4
New paradigms for early-phase clinical trials
James H. Doroshow
National Cancer Institute, Bethesda, MD, United States
from 2011 Molecular Targets and Cancer Therapeutics conference on November 12, 2011 3:30 PM-5:30 PM
Phasing out phase III trials: How much evidence do we need if the target is clearly hit?
Jaap Verweij
Erasmus University Medical Center - Daniel den Hoed Cancer Center, Rotterdam, Netherlands
from 2011 Molecular Targets and Cancer Therapeutics conference on November 12, 2011 3:30 PM-5:30 PM
Development of clinical trials incorporating genomic signatures: Lessons learned
Lisa M McShane
National Cancer Institute, Bethesda, MD, United States
from 2011 Molecular Targets and Cancer Therapeutics conference on November 12, 2011 3:30 PM-5:30 PM
Clinical trial designs for targeted therapies
John J. Crowley
Cancer Research and Biostatistics, Seattle, WA, United States
from 2011 Molecular Targets and Cancer Therapeutics conference on November 12, 2011 3:30 PM-5:30 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4